Effects of tafluprost treatment for 3 years in patients with normal-tension glaucoma

Overview of attention for article published in Clinical Ophthalmology, July 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 4 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

Three-year efficacy and safety of omidenepag isopropyl in patients with normal tension glaucoma

Article in Japanese Journal of Ophthalmology (April 2024)

Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China

Article in BMC Ophthalmology (August 2022)

One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma

Article in Journal of Ocular Pharmacology and Therapeutics (May 2022)